Corvus Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Corvus Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.6 USD/shares, a 400% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.92 USD/shares, a 43.8% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -0.56 USD/shares, a 37.1% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -0.89 USD/shares, a 13.6% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -1.03 USD/shares, a 415% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.33 +37.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$1 +$0.14 +13.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$1 -$1 -415% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $0 +$1.39 +87.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 -$2 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.